Literature DB >> 15978014

GABAB and CB1 cannabinoid receptor expression identifies two types of septal cholinergic neurons.

Gábor Nyíri1, Eszter Szabadits, Csaba Cserép, Ken Mackie, Ryuichi Shigemoto, Tamás F Freund.   

Abstract

Septohippocampal cholinergic neurons play key roles in learning and memory processes, and in the generation of hippocampal theta rhythm. The range of receptors for endogenous modulators expressed on these neurons is unclear. Here we describe GABA(B) 1a/b receptor (GABA(B)R) and type 1 cannabinoid receptor (CB(1)R) expression in rat septal cholinergic [i.e. choline acetyltransferase (ChAT)-positive] cells. Using double immunofluorescent staining, we found that almost two-thirds of the cholinergic cells in the rat medial septum were GABA(B)R positive, and that these cells had significantly larger somata than did GABA(B)R-negative cholinergic neurons. We detected CB(1)R labelling in somata after axonal protein transport was blocked by colchicine. In these animals about one-third of the cholinergic cells were CB(1)R positive. These cells again had larger somata than CB(1)R-negative cholinergic neurons. The analyses confirmed that the size of GABA(B)R-positive and CB(1)R-positive cholinergic cells were alike, and all CB(1)R-positive cholinergic cells were GABA(B)R positive as well. CB(1)R-positive cells were invariably ChAT positive. All retrogradely labelled septohippocampal cholinergic cells were positive for GABA(B)R and at least half of them also for CB(1)R. These data shed light on the existence of at least two cholinergic cell types in the medial septum: one expresses GABA(B)R and CB(1)R, has large somata and projects to the hippocampus, whereas the other is negative for GABA(B)R and CB(1)R and has smaller somata. The results also suggest that cholinergic transmission in the hippocampus is fine-tuned by endocannabinoid signalling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978014     DOI: 10.1111/j.1460-9568.2005.04146.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  17 in total

1.  The interaction between hippocampal GABA-B and cannabinoid receptors upon spatial change and object novelty discrimination memory function.

Authors:  Mohammad Nasehi; Niyousha Alaghmandan-Motlagh; Mohaddeseh Ebrahimi-Ghiri; Mohammad Nami; Mohammad-Reza Zarrindast
Journal:  Psychopharmacology (Berl)       Date:  2017-08-05       Impact factor: 4.530

2.  Identifying novel members of the Wntless interactome through genetic and candidate gene approaches.

Authors:  Jessica Petko; Trevor Tranchina; Goral Patel; Robert Levenson; Stephanie Justice-Bitner
Journal:  Brain Res Bull       Date:  2017-07-20       Impact factor: 4.077

3.  Physiological activation of cholinergic inputs controls associative synaptic plasticity via modulation of endocannabinoid signaling.

Authors:  Yanjun Zhao; Thanos Tzounopoulos
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

Review 4.  Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention.

Authors:  Mackenzie E Hofmann; Charles J Frazier
Journal:  Exp Neurol       Date:  2011-12-09       Impact factor: 5.330

Review 5.  Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate.

Authors:  K Rea; M Roche; D P Finn
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

Review 6.  Functional diversity on synaptic plasticity mediated by endocannabinoids.

Authors:  Roger Cachope
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

7.  Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans.

Authors:  Patrick D Skosnik; Mihály Hajós; Jose A Cortes-Briones; Chad R Edwards; Brian P Pittman; William E Hoffmann; Andrew R Sewell; Deepak C D'Souza; Mohini Ranganathan
Journal:  Neuropharmacology       Date:  2018-03-28       Impact factor: 5.250

Review 8.  Integrating endocannabinoid signaling in the regulation of anxiety and depression.

Authors:  An-Qi Yin; Feng Wang; Xia Zhang
Journal:  Acta Pharmacol Sin       Date:  2018-07-12       Impact factor: 6.150

9.  Presynaptic cell dependent modulation of inhibition in cortical regions.

Authors:  Afia B Ali
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

Review 10.  The endocannabinoid system in guarding against fear, anxiety and stress.

Authors:  Beat Lutz; Giovanni Marsicano; Rafael Maldonado; Cecilia J Hillard
Journal:  Nat Rev Neurosci       Date:  2015-12       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.